Nurix Therapeutics (NRIX) Short Interest Ratio & Short Volume $11.75 +0.13 (+1.10%) As of 03:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nurix Therapeutics Short Interest DataNurix Therapeutics (NRIX) has a short interest of 14.09 million shares, representing 20.01% of the float (the number of shares available for trading by the public). This marks a -0.21% decrease in short interest from the previous month. The short interest ratio (days to cover) is 14.0, indicating that it would take 14.0 days of the average trading volume of 845,082 shares to cover all short positions.Current Short Interest14,090,000 sharesPrevious Short Interest14,120,000 sharesChange Vs. Previous Month-0.21%Dollar Volume Sold Short$149.64 millionShort Interest Ratio14.0 Days to CoverLast Record DateMay 31, 2025Outstanding Shares76,240,000 sharesShort Percent of Float20.01%Today's Trading Volume137,994 sharesAverage Trading Volume845,082 sharesToday's Volume Vs. Average16% Short Selling Nurix Therapeutics? Sign up to receive the latest short interest report for Nurix Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNRIX Short Interest Over TimeNRIX Days to Cover Over TimeNRIX Percentage of Float Shorted Over Time Nurix Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/202514,090,000 shares $149.64 million -0.2%20.0%14 $10.62 5/15/202514,120,000 shares $133.58 million +3.1%20.1%14.4 $9.46 4/30/202513,690,000 shares $157.85 million -4.9%N/A14 $11.53 4/15/202514,390,000 shares $141.31 million +18.3%20.4%15.1 $9.82 3/31/202512,160,000 shares $144.46 million -0.1%17.3%13.9 $11.88 3/15/202512,170,000 shares $165.39 million +4.9%17.3%15.1 $13.59 2/28/202511,600,000 shares $179.22 million +2.1%16.5%15 $15.45 2/15/202511,360,000 shares $199.82 million +3.7%16.1%14.8 $17.59 1/31/202510,950,000 shares $215.82 million +0.7%N/A12.4 $19.71 1/15/202510,870,000 shares $219.03 million +0.7%N/A12.5 $20.15 Get the Latest News and Ratings for NRIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/31/202410,790,000 shares $203.28 million +9.8%N/A11.4 $18.84 12/15/20249,830,000 shares $199.25 million +5.1%N/A10.7 $20.27 11/30/20249,350,000 shares $206.73 million -2.6%N/A10.6 $22.11 11/15/20249,600,000 shares $220.03 million +1.5%N/A11.6 $22.92 10/31/20249,460,000 shares $232.53 million +2.4%N/A12.8 $24.58 10/15/20249,240,000 shares $229.80 million +1.8%N/A13.8 $24.87 9/30/20249,080,000 shares $204.03 million -3.0%N/A14.1 $22.47 9/15/20249,360,000 shares $232.13 million +1.1%N/A12.1 $24.80 8/31/20249,260,000 shares $233.35 million +0.2%N/A10.6 $25.20 8/15/20249,240,000 shares $204.76 million -0.9%N/A9.9 $22.16 7/31/20249,320,000 shares $203.92 million +5.4%N/A9.2 $21.88 7/15/20248,840,000 shares $200.49 million +9.5%N/A8.6 $22.68 6/30/20248,070,000 shares $168.42 million +6.2%N/A6.8 $20.87 6/15/20247,600,000 shares $115.37 million +2.8%N/A6.7 $15.18 5/31/20247,390,000 shares $116.39 million +1.5%N/A7 $15.75 5/15/20247,280,000 shares $115.75 million +5.5%N/A6.7 $15.90 4/30/20246,900,000 shares $82.94 million -2.0%N/A6.6 $12.02 4/15/20247,040,000 shares $108.84 million +1.0%N/A7.2 $15.46 3/31/20246,970,000 shares $102.46 million +8.7%N/A8.7 $14.70 3/15/20246,410,000 shares $83.84 million -6.4%N/A7.9 $13.08 2/29/20246,850,000 shares $84.60 million -5.8%N/A8.5 $12.35 2/15/20247,270,000 shares $71.61 million -0.3%N/A9.2 $9.85 1/31/20247,290,000 shares $57.59 million +4.0%16.5%10 $7.90 1/15/20247,010,000 shares $65.68 million +6.4%15.9%9 $9.37 12/31/20236,590,000 shares $68.01 million -25.4%14.9%8.4 $10.32 12/15/20238,830,000 shares $80.18 million +6.0%20.0%12.4 $9.08 11/30/20238,330,000 shares $51.81 million +12.0%18.9%14.7 $6.22 11/15/20237,440,000 shares $47.99 million +4.4%16.9%14.7 $6.45 10/31/20237,130,000 shares $39.86 million +9.0%16.2%15.4 $5.59 10/15/20236,540,000 shares $41.66 million +5.3%14.8%17.2 $6.37How to Collect Up To $5,917/mo From Trump’s Made In USA Boom (Ad)How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback. Watch Now to Learn How to Get Your First Check in 30 Days 9/30/20236,210,000 shares $48.81 million -1.1%14.2%18.8 $7.86 9/15/20236,280,000 shares $55.64 million +12.5%14.3%20.2 $8.86 8/31/20235,580,000 shares $47.43 million -2.6%12.7%17.4 $8.50 8/15/20235,730,000 shares $51.46 million +2.9%13.1%20.2 $8.98 7/31/20235,570,000 shares $54.08 million +3.5%12.7%19.2 $9.71 7/15/20235,380,000 shares $52.51 million +3.5%12.4%17.3 $9.76 6/30/20235,200,000 shares $51.95 million -1.3%12.1%15.5 $9.99 6/15/20235,270,000 shares $58.55 million +1.4%12.3%15.1 $11.11 5/31/20235,200,000 shares $52.62 million -3.0%12.1%14.6 $10.12 5/15/20235,360,000 shares $58.21 million +3.1%12.7%14.3 $10.86 4/30/20235,200,000 shares $50.08 million +6.6%12.3%13.4 $9.63 4/15/20234,880,000 shares $59.63 million -0.8%11.6%12.8 $12.22 3/31/20234,920,000 shares $43.69 million +1.9%11.7%14.5 $8.88 3/15/20234,830,000 shares $45.06 million +5.9%11.5%14.2 $9.33 2/28/20234,560,000 shares $43.00 million -2.6%10.9%14.1 $9.43 2/15/20234,680,000 shares $48.44 million -0.4%11.1%14.2 $10.35 1/31/20234,700,000 shares $57.76 million -3.1%11.2%13.7 $12.29 1/15/20234,850,000 shares $56.55 million +2.8%11.6%13.5 $11.66 12/30/20224,720,000 shares $51.83 million +0.2%11.2%12.2 $10.98 12/15/20224,710,000 shares $56.10 million -0.4%11.2%11.8 $11.91 11/30/20224,730,000 shares $58.60 million -8.0%11.3%11.6 $12.39 11/15/20225,140,000 shares $72.99 million -8.9%12.2%13 $14.20 10/31/20225,640,000 shares $71.80 million +13.5%13.7%13.7 $12.73 10/15/20224,970,000 shares $54.02 million +0.8%12.6%11.9 $10.87 9/30/20224,930,000 shares $64.24 million +5.1%12.5%11.9 $13.03 9/15/20224,690,000 shares $76.78 million -0.4%11.9%10 $16.37 8/31/20224,710,000 shares $74.09 million -7.8%12.0%9.8 $15.73 8/15/20225,110,000 shares $86.72 million -5.0%13.0%8.6 $16.97 7/31/20225,380,000 shares $85.86 million -0.7%13.8%9.1 $15.96 7/15/20225,420,000 shares $89.59 million -1.6%13.9%9.2 $16.53 6/30/20225,510,000 shares $69.81 million +7.6%14.8%9.5 $12.67 6/15/20225,120,000 shares $51.35 million +1.4%13.7%8.9 $10.03 5/31/20225,050,000 shares $50.95 million +19.7%13.5%9.2 $10.09 5/15/20224,220,000 shares $40.43 million +13.8%11.3%9.5 $9.58 4/30/20223,710,000 shares $41.07 million +7.2%10.2%8.5 $11.07 4/15/20223,460,000 shares $47.40 million +3.6%9.5%7.9 $13.70 3/31/20223,340,000 shares $46.79 million -13.3%9.2%7.4 $14.01 3/15/20223,850,000 shares $51.74 million +10.0%10.6%9.4 $13.44 2/28/20223,500,000 shares $56.60 million -13.6%9.6%10 $16.17 2/15/20224,050,000 shares $71.20 million +8.9%11.6%11.8 $17.58 1/31/20223,720,000 shares $69.27 million +7.8%11.1%11.4 $18.62 1/15/20223,450,000 shares $80.18 million +19.8%9.9%9.5 $23.24 12/31/20212,880,000 shares $83.38 million -2.0%8.3%8.7 $28.95 12/15/20212,940,000 shares $82.64 million -0.3%8.5%9.4 $28.11 11/30/20212,950,000 shares $85.02 million +2.4%8.5%8.8 $28.82 11/15/20212,880,000 shares $97.69 million -5.9%8.3%8.1 $33.92 10/29/20213,060,000 shares $102.36 million +1.7%9.1%9 $33.45 10/15/20213,010,000 shares $86.78 million -2.6%8.9%9.7 $28.83 9/30/20213,090,000 shares $92.58 million -1.0%9.2%7.9 $29.96 9/15/20213,120,000 shares $113.51 million -5.7%9.3%7.2 $36.38How to Collect Up To $5,917/mo From Trump’s Made In USA Boom (Ad)How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback. Watch Now to Learn How to Get Your First Check in 30 Days 8/31/20213,310,000 shares $106.55 million -5.2%9.9%7.6 $32.19 8/13/20213,490,000 shares $107.46 million -16.5%10.4%8.1 $30.79 7/30/20214,180,000 shares $128.49 million -9.5%14.4%9.3 $30.74 7/15/20214,620,000 shares $109.03 million -2.7%15.8%10.9 $23.60 6/30/20214,750,000 shares $126.02 million +10.0%16.3%12.5 $26.53 6/15/20214,320,000 shares $130.90 million -2.7%14.8%10.7 $30.30 5/28/20214,440,000 shares $123.88 million -7.1%15.2%9.9 $27.90 5/14/20214,780,000 shares $120.46 million -0.4%16.4%10.1 $25.20 4/30/20214,800,000 shares $166.75 million +8.6%19.1%9.6 $34.74 4/15/20214,420,000 shares $132.56 million +2.1%17.6%8.6 $29.99 3/31/20214,330,000 shares $122.63 million +60.4%19.2%8.5 $28.32 3/15/20212,700,000 shares $119.23 million +6.7%13.1%5.8 $44.16 2/26/20212,530,000 shares $84.55 million +7.7%16.7%7.1 $33.42 2/12/20212,350,000 shares $91.58 million +22.4%15.5%7.8 $38.97 1/29/20211,920,000 shares $72.06 million +5.5%9.5%7.2 $37.53 1/15/20211,820,000 shares $77.62 million No Change9.0%8.4 $42.65 NRIX Short Interest - Frequently Asked Questions What is Nurix Therapeutics' current short interest? Short interest is the volume of Nurix Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 31st, investors have sold 14,090,000 shares of NRIX short. 20.01% of Nurix Therapeutics' shares are currently sold short. Learn More on Nurix Therapeutics' current short interest. What is a good short interest ratio for Nurix Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NRIX shares currently have a short interest ratio of 14.0. Learn More on Nurix Therapeutics's short interest ratio. What is a good short interest percentage for Nurix Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 20.01% of Nurix Therapeutics' floating shares are currently sold short. Is Nurix Therapeutics' short interest increasing or decreasing? Nurix Therapeutics saw a decrease in short interest during the month of May. As of May 31st, there was short interest totaling 14,090,000 shares, a decrease of 0.2% from the previous total of 14,120,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Nurix Therapeutics' short interest compare to its competitors? 20.01% of Nurix Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Nurix Therapeutics: Avidity Biosciences, Inc. (14.07%), Arcellx, Inc. (16.66%), SpringWorks Therapeutics, Inc. (9.08%), Ultragenyx Pharmaceutical Inc. (6.38%), Protagonist Therapeutics, Inc. (9.24%), Scholar Rock Holding Co. (18.81%), Kymera Therapeutics, Inc. (12.09%), Viking Therapeutics, Inc. (25.15%), HUTCHMED (China) Limited (0.28%), Crinetics Pharmaceuticals, Inc. (11.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($64.96 billion), Invesco QQQ ($27.88 billion), iShares Russell 2000 ETF ($19.94 billion), iShares 20+ Year Treasury Bond ETF ($9.69 billion), MicroStrategy Incorporated ($8.58 billion), SPDR S&P Biotech ETF ($5.72 billion), Invesco S&P 500 Equal Weight ETF ($5.45 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.70 billion), Charter Communications, Inc. ($4.54 billion), and Industrial Select Sector SPDR Fund ($4.49 billion). View all of the most shorted stocks. What does it mean to sell short Nurix Therapeutics stock? Short selling NRIX is an investing strategy that aims to generate trading profit from Nurix Therapeutics as its price is falling. NRIX shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Nurix Therapeutics? A short squeeze for Nurix Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NRIX, which in turn drives the price of the stock up even further. How often is Nurix Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NRIX, twice per month. The most recent reporting period available is May, 31 2025. More Short Interest Resources from MarketBeat Related Companies Avidity Biosciences Short Interest Arcellx Short Interest SpringWorks Therapeutics Short Interest Ultragenyx Pharmaceutical Short Interest Protagonist Therapeutics Short Interest Scholar Rock Short Interest Kymera Therapeutics Short Interest Viking Therapeutics Short Interest HUTCHMED Short Interest Crinetics Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NRIX) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTop Picks for Trump’s Pro-Crypto America27 of crypto's most successful minds are about to pull back the curtain… Bitcoin has crushed its all-time h...Crypto 101 Media | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NRIX Stock Free NRIX Stock Alerts